About ANP Technologies
ANP Technologies is a company based in Newark (United States) founded in 2002. It operates as a B2B. ANP Technologies offers products and services including Nanoencapsulated Chemotherapeutics, PEG Immunogenicity ELISA Kit, mRNA-based Vaccines, and Antibody Therapies. ANP Technologies operates in a competitive market with competitors including Curative, Sirnaomics, Acorda, Liquidia and Genedit, among others.
- Headquarter Newark, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Anp Technologies, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of ANP Technologies
ANP Technologies offers a comprehensive portfolio of products and services, including Nanoencapsulated Chemotherapeutics, PEG Immunogenicity ELISA Kit, mRNA-based Vaccines, and Antibody Therapies.
Enhances solubility and efficacy for cancer treatments
Detects immunogenicity in pharmaceutical applications
Targets immune responses for disease prevention
Provides targeted treatments for infections and cancer
People of ANP Technologies
Unlock access to complete
Funding Insights of ANP Technologies
Detailed funding history for ANP Technologies
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by ANP Technologies
Investment portfolio details for ANP Technologies
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - ANP Technologies
Detailed financials for ANP Technologies
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Anp Technologies Comparisons
Peer comparison for ANP Technologies
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of ANP Technologies
ANP Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Curative, Sirnaomics, Acorda, Liquidia and Genedit, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Curative is recognized for providing affordable employer-sponsored health insurance.
|
|
| Locked | Locked | Locked |
RNA-based therapeutics for cancer and fibrosis are developed.
|
|
| Locked | Locked | Locked |
Engaged in the development and commercialization of therapies that improve neurological function.
|
|
| Locked | Locked | Locked |
Engineered particles & films for life and material sciences applications
|
|
| Locked | Locked | Locked |
Genetic medicines are delivered using polymer nanoparticle platforms.
|
|
| Locked | Locked | Locked |
Drug delivery systems to cell interiors are developed via nanosyringes.
|
Detailed competitors of ANP Technologies
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Anp Technologies
Complete news archive for ANP Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ANP Technologies
ANP Technologies was founded in 2002.
ANP Technologies is headquartered in Newark, United States. It is registered at Newark, New Jersey, United States.
ANP Technologies, based in Newark, Delaware, focuses on innovating nano-therapeutics for cancer therapies like leukemia and MDS. They use nanoparticle technology to enhance drug delivery, reduce toxicity, and improve efficacy through partnerships with entities such as Fulgent Pharma and Moffitt Cancer Center. The company licenses technologies to pharmaceutical firms and develops products for clinical applications.
ANP Technologies's top competitors include Sirnaomics, Arcturus Therapeutics and Acorda.
ANP Technologies offers Nanoencapsulated Chemotherapeutics, PEG Immunogenicity ELISA Kit, mRNA-based Vaccines, and Antibody Therapies.